Frequent loss of heterozygosity at 1p36 in ovarian adenocarcinomas but the gene encoding p73 is unlikely to be the target

Oncogene

Volumn 18, Issue 32, 1999, Pages 4640-4642

  Imyanitov, Evgeny N ^a   Birrell, Geoff W ^b   Filippovich, Igor ^c   Sorokina, Natasha ^c   Arnold, Jeremy ^b   Mould, Michelle A ^b   Wright, Kim ^b   Walsh, Michael ^d   Mok, Samuel C ^e   Lavin, Martin F ^b,d   Chenevix Trench, Georgia ^b,d   Khanna, Kum Kum ^b,d  

^a N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Loss of heterozygosity; Ovarian adenocarcinoma; p73; Tumour suppressor

Indexed keywords

MICROSATELLITE DNA; PROTEIN P53;

ARTICLE; CHROMOSOME 1P; CONTROLLED STUDY; FEMALE; GENE INACTIVATION; GENE MAPPING; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ADENOCARCINOMA; CHROMOSOMES, HUMAN, PAIR 1; DNA-BINDING PROTEINS; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0033549879     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202863     Document Type: Article

References (15)

1. Chenevix-Trench G, Kerr J, Friedlander M, Hurst T, Sanderson B, Coglan M, Ward B, Leary J and Khoo S-K. (1994). Am. J. Hum. Genet., 55, 1433-1449.
2. Chenevix-Trench G, Kerr J, Hurst T, Shih Y-C, Purdie D, Bergman L, Friedlander M, Sanderson B, Zournazi A, Coombs T, Leary JA, Crawford E, Shelling AN, Cooke I, Ganesan TS, Searle J, Choi C, Barrett JC, Khoo S-K and Ward B. (1997). Gene. Chromo. Cancer, 18, 75-83.
3. Dracopoli NC, Harnett P, Bale SJ, Stanger BZ, Tucker MA, Housman DE and Kefford RF. (1989). Proc. Natl. Acad. Sci., 86, 4614-4618.
4. Jost CA, Martin MC and Kaelin WG. (1997). Nature, 389, 191-194.
5. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan J-C, Valent A, Minty A, Chalon P, Lelias J-M, Dumont X, Ferrara P, McKeon F and Caput D. (1997). Cell, 90, 809-819.
6. Lundgren R, Mandahl N, Heim S, Limon J, Henrikson H and Mitleman F. (1992). Genes Chromosome Cancer, 4, 16-24.
7. Marin MC, Jost CA, Irwin MS, DeCaprio JA, Caput D and Kaelin WG. (1998). Mol. Cell. Biol., 18, 6316-6324.
8. Nagai H, Negrini M, Carter SL, Gillum DR, Rosenberg AL, Schwartz GF and Croce CM. (1995). Cancer Res., 55, 1752-1757.
9. Parkin DM, Pisani P and Ferlay J. (1993). Int. J. Cancer, 54, 594-606.
10. Shelling AN, Cooke IE and Ganesan T. (1995). Br. J. Cancer, 72, 521-527.
11. Teneriello MG, Ebina M, Linnoila RI, Henry M, Nash JD, Park RC and Birrer MJ. (1993). Cancer Res., 53, 3103 3108.
12. Thompson FH, Taetle R, Trent JM, Liu Y, Massey-Brown K, Scott KM, Weinstein RS, Emerson JC, Alberts DS and Nelson MA. (1997). Cancer Genet. Cytogenet., 96, 106-110.
13. Tsao S-W, Mok SC, Fey EG, Fletcher JA, Wan TSK, Chew E-C, Muto MG, Knapp RC and Berkowitz RS. (1995). Exp. Cell. Res., 218, 499-507.
14. Webb PM, Green A, Cummings M, Purdie D, Walsh M and Chenevix-Treneh G. J. Natl. Cancer Inst. (in press).
15. White PS, Maris JM, Beltinger C, Sulman E, Marshall HN, Fujimori M, Kaufman BA, Biegel JA, Allen C, Hillard C, Valentine MB, Look AT, Enomoto H, Sakiyama S and Brodeur GM. (1995). Proc. Natl. Acad. Sci. USA, 92, 5520-5524.